Novel protocol can help to rapidly diagnose eye stroke
Feb 21, 2024
Significant improvement in mean visual acuity was seen within 24 hours of treatment; clinically significant improvement occurred in 66%.
Single dose of zilebesiran linked to reduction in systolic BP
Feb 20, 2024
A significant reduction was seen in systolic blood pressure with zilebesiran 150, 300 or 600 mg once in six months and 300 mg once every three months.
AAOS: Sports-related orthopedic injuries in seniors projected to grow 123 percent by 2040
Feb 20, 2024
Demand from an increasing number of active older adults will outpace the growth in the number of orthopedic surgeons.
American Stroke Association, Feb. 7-9
Feb 20, 2024
The conference featured presentations that emphasized basic, clinical and translational medicine and provided insight into the prevention, management and treatment of stroke.
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.
Salt substitute can reduce incidence of hypertension among seniors
Feb 12, 2024
No increase was seen in the incidence of hypotension episodes with replacement of salt by a potassium-enriched substitute.
Environmental Protection Agency finalizes stronger air quality standards
Feb 09, 2024
The agency estimates that the new standard will prevent up to 4,500 premature deaths in the first year of full enforcement.
IV Ketamine not a ‘silver bullet’ for depression, but does help some
Feb 09, 2024
One-fourth with treatment-resistant depression show a response at six weeks.
ASA: Nearly one in five people develop dementia after stroke
Feb 08, 2024
In the first year after stroke, there is an almost threefold higher risk for dementia.
Reduced cancer risk seen after 10 years since quitting smoking
Feb 08, 2024
After 15 or more years since quitting, the cancer risk reached 50% of that associated with continued smoking.